Bristol-Myers Squibb Company
Imaging methods using 18F-radiolabeled biologics
Last updated:
Abstract:
The invention relates to water soluble .sup.18F-prosthetic groups and the synthesis and use .sup.18F-labeled biological molecules containing the .sup.18F-prosthetic groups for imaging various processes within the body, for detecting the location of molecules associated with disease pathology, and for monitoring disease progression are disclosed.
Status:
Grant
Type:
Utility
Filling date:
31 May 2017
Issue date:
4 May 2021